MedVi is a nationwide telehealth platform providing affordable, physician-supervised GLP-1 weight loss programs. Partnering with OpenLoop Health and FDA-regulated pharmacies, MedVi ensures high ...
The Endocrine Society and European Society of Endocrinology issued recommendations for the management of preexisting diabetes ...
Explainer - The popularity of Wegovy and Ozempic has seen a flood of ads pop up. Who can you trust?
The product is bioequivalent to Novo Nordisk Inc's Victoza injection. It is indicated as an adjunct to diet and exercise to ...
In new guidance to medics, the European Association for the Study of Obesity praised the drugs' effectiveness and significant ...
The European Association for the Study of Obesity recommends the GLP-1 injectables semaglutide and tirzepatide as first-line ...
Leqembi ® Iqlik™, a subcutaneous (SC) formulation of lecanemab, is now available as a maintenance dosing regimen for the treatment of Alzheimer disease in patients with mild cognitive impairment or ...
Ozempic may improve blood sugar a few weeks after starting, with full results appearing after about eight weeks. For weight ...
Today, Aisling’s doctor calls her the ‘poster girl for Ozempic’ because she’s bucked recent research by the University of ...
New LEQEMBI Companion™ program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who ...